Another study found that METTL3 advanced the expression of Integrin β1 (ITGB1) in a m6A-HuR-dependent manner, promoting the bone metastasis of prostate cancer cells [97] (Figure 2J). This evidence concerns the gene METTL3 and prostate carcinoma.